Pharmacologic Management of Presbyopia
Beyond Reading Glasses.
Course Overview
The approval of pharmacologic agents for presbyopia management represents a meaningful expansion of the optometric therapeutic toolkit. This Clinical Essential provides a practical foundation for understanding how these agents work, who they are appropriate for, and how to integrate them thoughtfully into a comprehensive presbyopia management strategy.
Clinical Relevance
Presbyopia affects virtually every patient over 40, yet the conversation in many practices remains limited to spectacle and contact lens options. Pharmacologic agents offer a complementary approach — one that requires clinical understanding of mechanism, patient selection, and realistic expectation-setting to be used effectively.
Course Details
Credit hours and COPE approval pending. Join the waitlist to receive notification when this course becomes available.
Learning Objectives
Upon successful completion of this educational experience, the clinician will be able to:
Explain the mechanism of action of currently approved pharmacologic presbyopia agents.
Identify appropriate candidates for pharmacologic presbyopia management based on clinical and lifestyle factors.
Counsel patients on realistic expectations, limitations, and the role of pharmacologic therapy within a broader management plan.
Recognize contraindications and potential adverse effects relevant to clinical practice.
Integrate pharmacologic options into a comprehensive, patient-centered presbyopia management strategy.
Course Modules
This educational experience is organized into the following modules. Content is subject to refinement prior to final release.
The Physiology of Presbyopia
Lens biomechanics, ciliary muscle function, and the accommodative system — understanding what changes and why.
Pharmacologic Mechanisms
Miosis-based approaches, depth-of-focus enhancement, and the optical principles underlying current pharmacologic agents.
Clinical Evidence
A review of the pivotal trial data supporting currently available agents — what the evidence shows and what it does not.
Patient Selection and Counseling
Identifying the right patient, setting appropriate expectations, and navigating the conversation about pharmacologic therapy as part of a broader plan.
Integration into Practice
Prescribing considerations, follow-up protocols, and combining pharmacologic management with optical correction strategies.
Educational Philosophy
This educational experience is designed to support clinical reasoning and evidence-informed decision-making. It does not constitute clinical advice and should not replace consultation of official prescribing information, applicable standards of care, or the clinical judgment of the treating clinician. COPE approval and credit hours are pending and will be confirmed prior to release.
Be the First to Know
Join the waitlist for Pharmacologic Management of Presbyopia and receive notification when this educational experience becomes available.
Companion Resource
The Clinician's Companion
Explore the therapeutic reference library designed to support the clinical reasoning developed in MYODCE educational experiences.
Explore the Companion